Victoza - Liraglutide 6 mg Solution For Injection

Liraglutide belongs to a class of medications known as GLP-1 (glucagon-like peptide-1) receptor agonists, which work by mimicking the action of a natural hormone involved in regulating blood sugar and appetite. By activating GLP-1 receptors, Liraglutide helps the body release insulin more effectively in response to meals, while also slowing stomach emptying and reducing feelings of hunger, supporting both blood sugar control and weight management goals. It is commonly used in adults with type 2 diabetes to help improve blood sugar control as part of a comprehensive treatment plan that includes diet and exercise. Liraglutide is also used, often at a different dose, to support weight management in appropriate individuals, given its beneficial effect on appetite regulation and satiety. The pre-filled syringe format offers a convenient, ready-to-use option for self-administered subcutaneous injection, typically given once daily. Dosing usually starts at a lower level and is gradually increased over time, as directed by a healthcare provider, to help the body adjust comfortably. Many patients experience meaningful improvements in blood sugar control and body weight with consistent, long-term use. Regular follow-up with a healthcare provider helps monitor progress and adjust treatment as needed. As with all injectable medications, Liraglutide should be used under the guidance of a healthcare provider as part of a personalized care plan.